Advertisements

Д-сорбитол

Quick links to important sections

Д-сорбитол

Advertisements
Advertisements

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Д-сорбитол

What is D-Sorbitol?

D-sorbitol, also known as glucitol, is a type of sugar alcohol (polyol) that occurs naturally in various fruits and berries, such as apples, pears, peaches, and prunes. It is a stereoisomer of mannitol and is characterized by its sweet taste and hygroscopic properties, meaning it has a natural ability to attract and hold water molecules.

Chemical Nature and Production

At a molecular level, D-sorbitol is a six-carbon sugar alcohol. It is produced commercially through the hydrogenation of glucose. Unlike sucrose (table sugar), sorbitol is not a "sugar" in the traditional sense; it is a carbohydrate that is more slowly and incompletely absorbed by the digestive system.

Role in the Body and Metabolism

When consumed, D-sorbitol undergoes a specific metabolic pathway. It is primarily metabolized in the liver, where it can be converted into fructose by the enzyme sorbitol dehydrogenase. Because it is absorbed slowly, it has a lower glycemic index compared to glucose, resulting in a significantly reduced effect on blood glucose levels.

Physical Properties

D-sorbitol is highly valued in various formulations for several key characteristics:

  • Solubility: It dissolves easily in water.
  • Humectant Properties: It helps products retain moisture, preventing them from drying out.
  • Sweetness: It provides approximately 60% of the sweetness of sucrose but with fewer calories per gram.
  • Osmotic Activity: Due to its molecular structure, it can exert osmotic pressure, drawing water into the intestinal lumen when present in high concentrations.

Regulatory References

  1. World Health Organization (WHO) Essential Medicines List
  2. WHO Essential Medicines List
Advertisements

What side effects are possible with Д-сорбитол?

Possible side effects and safety information

The safety profile of Sorbitol reflects its core osmotic action, primarily affecting fluid and electrolyte balance across the body. Official regulatory documents often classify the frequency of adverse reactions as not defined, indicating incidence rates are commonly derived from general use rather than controlled clinical trials.

Adverse reactions are grouped by the physiological system they affect, as documented in official prescribing information:

  • Gastrointestinal disorders: Frequently reported effects include diarrhea, nausea, vomiting, abdominal discomfort, and excessive bowel activity.
  • Metabolism and nutrition disorders: These can include electrolyte depletion, hypovolemia (decreased blood volume), hyperglycemia, and lactic acidosis.

Documented Safety Constraints

Certain safety considerations and contraindications are explicitly noted in regulatory labeling:

  • Hereditary Fructose Intolerance (HFI): The product is an absolute contraindication for patients with this metabolic disorder, as Sorbitol is metabolized into Fructose, posing a significant systemic risk.
  • Existing Conditions: Use requires caution in patients with severe cardiopulmonary or renal impairment due to the potential for large volumes to cause fluid overload or electrolyte changes. Individuals with diabetes mellitus should be monitored for the risk of hyperglycemia.
  • Restrictions: Oral or rectal use is generally restricted in the presence of acute abdominal pain, nausea, or vomiting.

Serious adverse events cited in regulatory documentation include the potential for significant fluid and electrolyte losses and, in the context of specific drug combinations, the risk of intestinal necrosis.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation strictly defines the overdose profile for Д-сорбитол (Sorbitol) based on its profound osmotic effects. Overdose is primarily characterized by the clinical signs of excessive catharsis, leading to profuse diarrhea, nausea, vomiting, and abdominal discomfort. The critical documented consequences are significant fluid and electrolyte losses, which may result in severe dehydration, hypernatremia, and life-threatening electrolyte imbalance.

Overdose scenarios involving the systemic absorption of large volumes, such as during irrigation procedures, are also associated with the risk of fluid overload and potential alterations to cardiopulmonary and renal dynamics. A specific pharmacological antidote for Sorbitol overdose is not documented in official labeling.

Required Emergency Action

In the event of a suspected overdose, the official labeling mandates immediate action: individuals must seek medical help or contact a Poison Control Center right away. Due to the risk of severe physiological instability, medical attention is required. Management of overdose is supportive and symptomatic, focusing on intensive monitoring and correction of the fluid and electrolyte status. Elderly and pediatric patients are noted as being susceptible to severe fluid and electrolyte disturbances and require especially careful monitoring.

Advertisements

Therapeutic Uses of Д-сорбитол

What Д-сорбитол treats: main uses and benefits

The primary therapeutic applications of this compound may assist with managing symptoms related to systemic imbalance and digestive discomfort. Its active ingredient is considered relevant for short-term symptomatic assistance.

Its use is relevant across domains, including managing functional constipation, supporting fluid dynamics and clearance protocols, and assisting with hepatobiliary function.

Addressing Infrequent Bowel Movements and Functional Constipation

This medicine is commonly used across conditions characterized by periods of heightened symptoms related to digestive discomfort, specifically functional constipation. It helps address symptom clusters that may become intense or disruptive, such as infrequent or difficult bowel movements and stool hardening. It provides support that helps ease the overall symptom burden and contributes to improved comfort during these periods of digestive sluggishness.

“When symptoms create noticeable physiological strain, supportive relief that helps maintain functional stability is often important.”

Supporting Systemic Fluid Balance and Clearance Protocols

Д-сорбитол is applied across domains where additional symptomatic support is needed for systemic detoxification and fluid dynamics management. It may assist with managing symptoms related to systemic imbalance or the accumulation of excess fluid. This supportive therapeutic use helps maintain a sense of stability when the body is under a heightened systemic burden, by promoting the clearance of fluid and specific metabolic wastes. The medication is relevant for easing symptoms linked to sluggish biliary tract function. This support assists with maintaining functional stability during episodes of digestive discomfort.


Quick Fact: Relief for Digestive and Systemic Stress

Symptom Domain Key Benefit Clinical Context
Constipation Softens stool, promotes easier elimination. Acute or episodic digestive discomfort.
Fluid Imbalance Supports enhanced diuresis and waste clearance. Situations requiring temporary fluid dynamics management.
Biliary Sluggishness Assists with bile flow and overall digestive clearance. Functional disturbances in hepatobiliary activity.
Advertisements

Eligibility and Restrictions for Use

The eligibility profile for Д-сорбитол is defined by regulatory agencies based on metabolic safety and fluid management risks.


Populations for Whom Use is Contraindicated

The medicine is strictly contraindicated in patients with hereditary fructose intolerance (HFI), as the body converts sorbitol into fructose, which can be toxic. Use is also prohibited in patients with known hypersensitivity to sorbitol. Non-eligibility rules extend to conditions like anuria (for irrigation solutions), severe dehydration, or, for oral forms, acute abdominal pain or intestinal obstruction.


Age-Related and Conditional Restrictions

Age Group Regulatory Status / Limitation
Infants/Young Children Highly restricted; use in infants is often not recommended due to HFI risk, and safety is often not established for pediatric use.
Older Adults Generally permitted, but caution advised due to higher prevalence of renal/cardiac conditions.

Conditional use is required in patients with renal dysfunction, severe cardiopulmonary disease, or diabetes mellitus, where the medicine must be used with caution. During pregnancy and lactation, use is conditional, permitted only if clearly needed due to a lack of established human safety data.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The officially documented interaction profile for D-Sorbitol (Д-сорбитол) is structured around two main categories of risk: interactions affecting fluid and electrolyte balance, and pharmacokinetic alterations that change the systemic exposure of co-administered drugs.


Interaction Domains and Practical Implications

Interaction Domain Official Regulatory Concern
Potassium-Depleting and Dehydrating Agents Increased risk or severity of dehydration and/or electrolyte imbalance when combined with agents such as Acetazolamide or Amiloride.
Drugs with Decreased Efficacy Reduced therapeutic efficacy may occur for certain co-administered medicines (e.g., Aclidinium, Alfentanil, Amitriptyline) due to changes in absorption or transit.
Altered Excretion Rate Co-administration can decrease the excretion rate of numerous medicines (e.g., Acyclovir, Amikacin), potentially leading to higher plasma concentrations of the interacting drug.
Agents Affecting Sorbitol Excretion Certain medicines (e.g., Acetaminophen, Acetylsalicylic acid) may decrease the excretion rate of Sorbitol itself, potentially leading to increased Sorbitol serum levels.

This interaction structure necessitates careful supervision, particularly when Sorbitol is combined with other agents that affect fluid homeostasis or when the efficacy of a co-administered medicine is critical and reliant on consistent systemic exposure. Official labeling requires consideration of these effects to manage overall patient risk.

Advertisements

Mechanism of Action

How Д-сорбитол Works: Mechanism of Action

Д-сорбитол functions as an osmotic agent primarily within the lumen of the small and large intestines, which serves as its main functional target. Due to its limited systemic absorption, the unabsorbed polyol creates a high solute concentration, establishing an osmotic gradient. This gradient actively draws and retains water from the systemic circulation across the intestinal mucosa and into the lumen.

The resulting increase in intraluminal fluid raises the bulk and turgor of the stool. This augmented volume induces a mechanical distension of the colonic wall, engaging mechanoreceptors embedded in the enteric nervous system. This mechanical signal activates the intrinsic propulsive motor sequence (peristalsis), initiating a physiological adjustment in bowel transit. The fraction that proceeds to the colon also undergoes partial fermentation by gut flora, which yields short-chain fatty acids, contributing a secondary osmotic effect and reinforcing the localized pathway effect on water retention.

Advertisements

Dosage and Administration Information

How to use Д-сорбитол

The administration of Sorbitol (Д-сорбитол) involves specific routes and dosage concentrations. The administration methods include Oral, Rectal (as an enema), and Irrigation via transurethral instillation.

Standard Use and Dosing

For oral use, the standard adult regimen specifies a single dose of the 70% solution, typically ranging from 30 mL to 150 mL. For rectal administration, a single dose of 120 mL of the 25% to 30% solution is prescribed. The dosing frequency is structured as a single dose at infrequent intervals or as needed. Continuous use is generally limited to not more than seven days. In certain adjunct protocols, the 70% oral solution may be repeated in 10 mL to 20 mL volumes every two hours.

Procedural and Population Rules

Dosage adjustments for pediatric patients involve reduced volumes calculated by weight (e.g., 2 mL/kg oral) or specified ranges for rectal use for children under 12 years. The irrigation solution is administered in a continuous flow during procedures and is not for injection. The container height for the irrigation solution should not be in excess of 60 cm above the operating field to control systemic absorption. Solutions used for irrigation must be discarded promptly after use.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Д-сорбитол

The research for Sorbitol examines its role across several functional domains. This overview summarizes the structure of the evidence and areas where information is still developing, without providing clinical advice or treatment recommendations.


Evidence for Use in Managing Functional Constipation

Studies were conducted using short-term Randomized Controlled Trials (RCTs) and comparative designs, applied in research contexts exploring outcomes related to infrequent or difficult bowel movements. These studies monitored outcomes related to physical discomfort and daily functioning.

Studies comparing Sorbitol to other established osmotic agents (such as lactulose) contribute to the broader evidence landscape. Findings describe patterns observed in these studies, showing that measurements of stool frequency and consistency were comparable to the effects observed with other similar treatments. Research also describes patterns observed in patient-reported outcomes describing perceived discomfort related to straining.

Long-term outcomes and the durability of effects beyond short-term intervention periods are not fully established. Follow-up durations were limited in many comparative trials, typically lasting only a few weeks.


Research on Systemic Fluid Dynamics and Clearance Protocols

The compound was studied for its role as an osmotic agent in systemic fluid management, aligning with its pharmacological classification. Research here is primarily based on mechanistic physiological studies and data gathered in specialized surgical contexts. The research examined temporary physiological imbalance related to fluid volume.

Certainty remains low regarding the full range of specific clinical applications for systemic diuresis, and long-term effects on electrolyte balance are not fully established. The evidence base for Sorbitol's systemic diuretic use is limited, as major dedicated human RCTs focusing on specific high-acuity indications are not widely available.


Evidence for Assisting with Hepatobiliary Function

The compound was studied for a role as a choleretic agent, which involves supporting bile flow. However, evidence regarding this specific use in human clinical trials is characterized by a significant research gap.

Data for this specific functional domain remain insufficient, and the clinical relevance is primarily inferred from basic science. Certainty remains low in this area due to the scarcity of dedicated, high-quality human clinical trials.

Key Studies & References

  1. The treatment of chronic constipation in adults: a systematic review
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Д-сорбитол (FAQ)

Q: Is Д-сорбитол the same thing as the sweetener sorbitol found in food?

The active ingredient in the medicine, Sorbitol, is described as the same chemical compound (a polyol) often used as a food additive or sweetener. However, for pharmaceutical use, the substance is required to meet official purity and quality standards, such as those defined by regulatory references like the USP (United States Pharmacopeia) or BP (British Pharmacopoeia).

Q: Are there any long-term effects of using Д-сорбитол regularly?

Official instructions for non-prescription use often constrain continuous administration to a short period, typically not more than seven days. The long-term effects of use beyond this short period are generally not established in current research documentation.

Q: Can people with kidney problems typically use Д-сорбитол?

Official labeling advises exercising caution in patients who have severe renal impairment (significant kidney problems). This caution is advised due to the described potential for fluid overload or changes in the body’s balance of electrolytes.

Q: Can it be used during pregnancy, according to official guidelines?

Official guidelines describe that use during pregnancy and lactation is generally permitted only if a healthcare professional determines it is clearly needed. This conditional status is noted due to a lack of established, comprehensive human safety data in these specific populations.

Q: Can patients with diabetes use the drug form of Д-сорбитол?

Official safety information indicates that patients with diabetes mellitus should be monitored for the risk of hyperglycemia (elevated blood sugar) when using this medicine. This is a listed caution in the official documents.

Q: Does taking Д-сорбитол with food change how it works?

Regulatory prescribing information focuses on the compound’s core osmotic mechanism of action. Official labeling does not typically contain explicit warnings or instructions about the effects of co-ingestion with food on the primary action or safety profile.

Q: What is the main difference between Д-сорбитол and regular sugar?

Sorbitol is chemically classified as a sugar alcohol (a polyol), while common table sugar (sucrose) is a disaccharide. Because the body absorbs sorbitol slowly and incompletely, regulatory guidelines note it provides fewer calories per gram than standard sugar and may have a reduced effect on blood glucose.

Q: Is a small amount of bloating normal after using Д-сорбитол?

Official adverse effects information lists abdominal discomfort and excessive bowel activity as potential reactions to the product. Regulatory documents describe side effects but do not generally categorize a small amount of bloating as a 'normal' or 'expected' part of the process.

Q: Does Д-сорбитол interact with common over-the-counter pain relievers?

Official labeling includes information that co-administration with certain common over-the-counter medicines, such as Acetaminophen and Acetylsalicylic acid, may decrease the body's rate of eliminating Sorbitol. This potential change may lead to increased Sorbitol levels in the serum.

Q: Can it be used frequently lead to a dependence on its primary action?

While official documents restrict continuous use to a short period, such as not more than seven days, to discourage misuse, the specific term 'dependence' related to laxative effect is not typically used in the Adverse Effects or Warnings sections of regulatory labeling.

Q: Is the drug ever used in combination with other active ingredients?

Yes, regulatory information confirms Sorbitol is used in combination with other active ingredients, such as Docusate or Glycerin, in certain approved combination drug products. These combination products are often intended for managing constipation.

Q: Does Д-сорбитол have a caloric value that needs to be considered?

Yes, regulatory and nutritional guidelines state that sorbitol does have a caloric value. It contributes approximately 2.6 calories per gram, a value that is lower than the four calories per gram typically associated with standard carbohydrates.

Q: Is it typical to feel thirsty after taking Д-сорбитол?

The feeling of thirst itself is not typically listed as a direct side effect. However, official adverse reaction information does include the risk of fluid and electrolyte losses and dehydration, of which thirst is a known physiological symptom.

Q: Is the name 'Д-сорбитол' used internationally, or are there other names?

The active ingredient is internationally known by its chemical name D-Glucitol and its official International Nonproprietary Name (INN), Sorbitol. The name Д-сорбитол is a common name used in specific regions or by specific manufacturers.

Q: How is the interaction with heart medication generally described in regulatory texts?

Regulatory labeling advises caution when using the drug in patients with severe cardiopulmonary impairment. The official interaction profile is structured around the increased risk of fluid and electrolyte imbalance when combined with other agents that affect heart function or fluid homeostasis.

Q: Why is the drug sometimes given intravenously in specific medical settings?

Official information indicates that the drug is formulated as a Solution for infusion for systemic use. It is classified as an Osmotic Diuretic, and this route is used to assist with fluid management in specialized medical or surgical settings, such as urologic irrigation.

Q: Are there different grades or types of sorbitol used in medicines?

Yes, regulatory agencies and pharmacopeial standards recognize different quality levels and forms of sorbitol. These are often designated by official quality control initials like USP (United States Pharmacopeia) Grade or BP (British Pharmacopoeia) Grade to ensure appropriate purity for use in medicines.

Advertisements

How should Д-сорбитол be stored and disposed of?

Storage and Disposal of D-Sorbitol Solution

The storage and disposal instructions for D-Sorbitol (Sorbitol) solution are strictly governed by regulatory labeling to maintain the product's integrity and ensure safety.

Storage Requirements

Condition Requirement
Temperature Range Store at Controlled Room Temperature (15 C to 30 C / 59 F to 86 F).
Freezing Restriction The solution must not freeze.
Child Safety Keep out of reach of children.

Stability and Handling

The contents of an opened container, particularly for irrigation solution, must be used promptly. Any unused portion must be discarded immediately because the solution lacks preservatives, which minimizes the risk of bacterial contamination.

Disposal Instructions

Unused or expired D-Sorbitol should be disposed of using a drug take-back location. Alternatively, disposal in the household trash is permitted after mixing the medicine with an unappealing substance and sealing it in a plastic bag. All personal information on the packaging must be removed or scratched out before discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Д-сорбитол found in:

A-Z Index: